InsidersTradesSigma
Follow the 셀리드 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 셀리드 has published 4 insider filings. Market capitalisation: €51.3bn. The latest transaction was reported on 6 May 2026 (Purchase). Among the most active insiders: 강창율. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
셀리드 opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se enfoca en el desarrollo de soluciones innovadoras en el campo de la atención médica.